January 2024

HqO Further Scales People-Centric Product Portfolio and Continues Rapid Global Expansion BOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — HqO, the world’s leading real estate experience platform, announced today its strategic acquisition of Symbiosy, a workspace technology created by international workspace provider HB Reavis, which offers a portfolio of smart building solutions consisting of systems integrations, […]

HqO Further Scales People-Centric Product Portfolio and Continues Rapid Global Expansion BOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — HqO, the world’s leading real estate experience platform, announced today its strategic acquisition of Symbiosy, a workspace technology created by international workspace provider HB Reavis, which offers a portfolio of smart building solutions consisting of systems integrations, […]

HqO Further Scales People-Centric Product Portfolio and Continues Rapid Global Expansion BOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — HqO, the world’s leading real estate experience platform, announced today its strategic acquisition of Symbiosy, a workspace technology created by international workspace provider HB Reavis, which offers a portfolio of smart building solutions consisting of systems integrations, […]

HqO Further Scales People-Centric Product Portfolio and Continues Rapid Global Expansion BOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — HqO, the world’s leading real estate experience platform, announced today its strategic acquisition of Symbiosy, a workspace technology created by international workspace provider HB Reavis, which offers a portfolio of smart building solutions consisting of systems integrations, […]

SHANGHAI, China, Jan. 09, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from TORCHLIGHT (NCT04085276), a randomized, double-blind, placebo-controlled phase 3 study comparing the efficacy and safety of […]

SHANGHAI, China, Jan. 09, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from TORCHLIGHT (NCT04085276), a randomized, double-blind, placebo-controlled phase 3 study comparing the efficacy and safety of […]

VICTOR, N.Y., Jan. 09, 2024 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that it priced the public offering of $400.0 million aggregate principal amount of 4.800% Senior Notes due 2029 (the “notes”) for a public offering price of 99.889% of the principal amount of the notes. The […]

Neil Spector to serve as strategic advisor, effective January 16 JERSEY CITY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today announced that Doug Caccese and Saurabh Khemka will serve as co-presidents of Verisk Underwriting Solutions as Neil Spector moves into a strategic advisor role, […]

Companies partner to provide patients and sites with easy access to study information in one integrated solution DURHAM, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an industry partnership with founding members Veeva Systems Inc., a leading provider of industry cloud solutions […]

Companies partner to provide patients and sites with easy access to study information in one integrated solution DURHAM, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an industry partnership with founding members Veeva Systems Inc., a leading provider of industry cloud solutions […]